# Iacopo Petrini

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/iacopo-petrini/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,993 |
| Field | Myasthenia Gravis and Thymoma |
| h-index | 34 |
| i10-index | 71 |
| Last Known Institution | University of Pisa |
| OpenAlex ID | https://openalex.org/A5013433148 |
| ORCID iD | 0000-0002-7752-6866 |
| Works | 198 |

## Researcher papers

- [PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer](https://scholariq.org/papers/pten-expression-and-kras-mutations-on-primary-tumors-and-metastases-in-the/)
- [A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors](https://scholariq.org/papers/a-specific-missense-mutation-in-gtf2i-occurs-at-high-frequency-in-thymic/)
- [PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC](https://scholariq.org/papers/pd-l1-mrna-expression-in-plasma-derived-exosomes-is-associated-with-response-to/)
- [Thymic Malignancies: From Clinical Management to Targeted Therapies](https://scholariq.org/papers/thymic-malignancies-from-clinical-management-to-targeted-therapies/)
- [The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer](https://scholariq.org/papers/the-mitochondrial-citrate-carrier-slc25a1-drives-stemness-and-therapy-resistance/)
- [Mutations of epigenetic regulatory genes are common in thymic carcinomas](https://scholariq.org/papers/mutations-of-epigenetic-regulatory-genes-are-common-in-thymic-carcinomas/)
- [MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma](https://scholariq.org/papers/microrna-expression-and-clinical-outcomes-in-patients-treated-with-adjuvant/)
- [Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing](https://scholariq.org/papers/detecting-cell-of-origin-and-cancer-specific-methylation-features-of-cell-free/)
- [Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors](https://scholariq.org/papers/copy-number-aberrations-of-bcl2-and-cdkn2a-b-identified-by-array-cgh-in-thymic/)
- [Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours](https://scholariq.org/papers/treatment-driven-tumour-heterogeneity-and-drug-resistance-lessons-from-solid/)
- [From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC](https://scholariq.org/papers/from-the-beginning-to-resistance-study-of-plasma-monitoring-and-resistance/)

## Researcher topics

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)

## Researcher university

- [University of Pisa](https://scholariq.org/institutions/university-of-pisa/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.